-+ 0.00%
-+ 0.00%
-+ 0.00%

RevMed executives said the pancreatic cancer oral medication was officially launched today and is priced at $39,800 per month.

Zhitongcaijing·08/26/2026 17:57:05
Listen to the news
RevMed executives said the pancreatic cancer oral medication was officially launched today and is priced at $39,800 per month.